FGF23 and myeloid sarcoma: Finally, given the high incidence of reduced bone mineral density and the still partially unknown mechanisms that affect bone turnover in MS patients [66], further studies should be performed to evaluate the relationship between change in the vitamin D-FGF23 axis, BMD, and fracture risk in both male and female MS patients.